Skip to main content
Back to Discussions

Can We Trust the FDA? Marty Makary on Science, Power & Patients

Healthcare
United States
Started January 16, 2026

(0:00) Friedberg intros FDA Commissioner Marty Makary (3:21) Inside the 42 major FDA reforms in 10 months (7:51) The China Race: Winning back biotech leadership (13:14) Accelerating drug approvals safely, how to cut down on clinical trial timelines (33:13) Reshaping the failed Food Pyramid (41:29) GLP-1s and America's Obesity Epidemic (49:54) Rethinking vaccines from first principles (59:40) Lowering drug prices, the power of AI for healthcare (1:18:57) What causes autism? Follow Marty Makary...

Source Articles

Add Statement Analysis 0/5
🗳️ Join the conversation
5 statements to vote on • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ statements, 50+ votes
Statements 5/7
Total Votes 0/50
💡 Keep voting and adding statements to unlock consensus insights

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Posted by will • Jan 16, 2026
While AI has potential in healthcare, its application in lowering drug prices must be approached cautiously to avoid unintended consequences.
💬 View Discussion
Be first to respond
0 total votes
CLAIM Posted by will • Jan 16, 2026
The debate over the FDA's role in drug approval highlights the need for a balanced approach that prioritizes both innovation and patient safety.
💬 View Discussion
Be first to respond
0 total votes
CLAIM Posted by will • Jan 16, 2026
Accelerating drug approvals may compromise safety standards, leading to potential risks for patients that outweigh the benefits of faster access.
💬 View Discussion
Be first to respond
0 total votes
CLAIM Posted by will • Jan 16, 2026
Rethinking the Food Pyramid is crucial to combat America's obesity epidemic, as outdated guidelines fail to address current dietary challenges.
💬 View Discussion
Be first to respond
0 total votes
CLAIM Posted by will • Jan 16, 2026
The FDA's recent reforms demonstrate a commitment to faster drug approvals, which can significantly benefit patients in need of timely treatments.
💬 View Discussion
Be first to respond
0 total votes

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us